Global Bone Graft And Substitute Market Forecast 2023-2032

Global Bone Graft And Substitute Market Forecast 2023-2032


KEY FINDINGS

The global bone graft and substitute market is set to record a CAGR of 5.40% during the forecast period, 2023-2032. The growth of the global bone graft and substitute market can be accredited to the growing prevalence of bone and joint issues, the increasing demand for dental bone grafts, and the rapid technological advancements in the field.

MARKET INSIGHTS

The rise in orthopedic surgeries, such as joint replacements and spinal fusions, has significantly driven the demand for bone grafts and substitutes. This trend is expected to continue with the aging global population. Whereas innovative materials and techniques, including synthetic bone grafts, biologics, and 3D printing, are enhancing the effectiveness of bone grafts and substitutes. These advancements are improving patient outcomes and reducing recovery times.

Further, the rising incidence of musculoskeletal disorders underscores the increasing importance of treatments and surgeries in managing these conditions, directly influencing the growth of the bone graft and substitute market. According to data from the World Health Organization (WHO), in 2021, around 1.71 billion people worldwide were affected by musculoskeletal conditions, encompassing ailments such as arthritis, low back pain, fibromyalgia, gout, and tendonitis. Factors like age, physical inactivity, and obesity are key contributors to the ongoing rise in musculoskeletal disorders, especially among the adult population. Moreover, the impact of musculoskeletal disorders is significant and widespread, making them the leading cause of severe, long-lasting pain and physical disability.

REGIONAL INSIGHTS

The global bone graft and substitute market growth analysis includes the geographical segmentation of North America, Europe, Asia-Pacific, and Rest of World. Asia-Pacific is the fastest-growing region accredited to the significant growth in healthcare expenditure, fueled by economic expansion and an increasing middle-class demographic.

COMPETITIVE INSIGHTS

Some of the leading market players include Orthofix Holdings Inc, SigmaGraft, Stryker Corporation, Smith & Nephew Plc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.5. Major Market Findings
2.5.1. Growing Treatments And Surgeries Involving Musculoskeletal Disorders
2.5.2. Technological Advancements
3. Market Dynamics
3.1. Key Drivers
3.1.1. Rising Spinal Fusion And Joint Reconstruction Surgeries
3.1.2. Degenerative Joint Diseases Due To Unhealthy Lifestyle Choices
3.1.3. Expanding Aging Population
3.2. Key Restraints
3.2.1. Ethical Issues Associated With Bone Grafting Procedures
3.2.2. High Costs Of Surgeries
3.2.3. Stringent Regulatory Approval Process
3.2.4. Surgical Risks Related To Immune Rejection
4. Key Analytics
4.1. Key Market Trends
4.2. Porter’s Five Forces Analysis
4.2.1. Buyers Power
4.2.2. Suppliers Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Growth Prospect Mapping
4.4. Market Maturity Analysis
4.5. Market Concentration Analysis
4.6. Key Buying Criteria
4.6.1. Cost-effectiveness
4.6.2. Application
4.6.3. Effectiveness
5. Market By Type
5.1. Allografts
5.1.1. Demineralized Bone Matrix
5.1.2. Other Allografts
5.2. Autografts
5.3. Synthetics And Additives
5.3.1. Ceramic
5.3.2. Composite
5.3.3. Polymer
5.3.4. Bone Morphogenetic Proteins
6. Market By Application
6.1. Spinal Fusion
6.1.1. Market Forecast Figure
6.1.2. Segment Analysis
6.2. Long Bone
6.2.1. Market Forecast Figure
6.2.2. Segment Analysis
6.3. Foot And Ankle
6.3.1. Market Forecast Figure
6.3.2. Segment Analysis
6.4. Craniomaxillofacial
6.4.1. Market Forecast Figure
6.4.2. Segment Analysis
6.5. Joint Reconstruction
6.5.1. Market Forecast Figure
6.5.2. Segment Analysis
6.6. Dental
6.6.1. Market Forecast Figure
6.6.2. Segment Analysis
7. Geographical Analysis
7.1. North America
7.1.1. Market Size & Estimates
7.1.2. North America Bone Graft And Substitute Market Drivers
7.1.3. North America Bone Graft And Substitute Market Challenges
7.1.4. North America Bone Graft And Substitute Market Regulatory Framework
7.1.5. Key Players In North America Bone Graft And Substitute Market
7.1.6. Country Analysis
7.1.6.1. United States
7.1.6.1.1. United States Bone Graft And Substitute Market Size & Opportunities
7.1.6.2. Canada
7.1.6.2.1. Canada Bone Graft And Substitute Market Size & Opportunities
7.2. Europe
7.2.1. Market Size & Estimates
7.2.2. Europe Bone Graft And Substitute Market Drivers
7.2.3. Europe Bone Graft And Substitute Market Challenges
7.2.4. Europe Bone Graft And Substitute Market Regulatory Framework
7.2.5. Key Players In Europe Bone Graft And Substitute Market
7.2.6. Country Analysis
7.2.6.1. United Kingdom
7.2.6.1.1. United Kingdom Bone Graft And Substitute Market Size & Opportunities
7.2.6.2. Germany
7.2.6.2.1. Germany Bone Graft And Substitute Market Size & Opportunities
7.2.6.3. France
7.2.6.3.1. France Bone Graft And Substitute Market Size & Opportunities
7.2.6.4. Italy
7.2.6.4.1. Italy Bone Graft And Substitute Market Size & Opportunities
7.2.6.5. Spain
7.2.6.5.1. Spain Bone Graft And Substitute Market Size & Opportunities
7.2.6.6. Belgium
7.2.6.6.1. Belgium Bone Graft And Substitute Market Size & Opportunities
7.2.6.7. Poland
7.2.6.7.1. Poland Bone Graft And Substitute Market Size & Opportunities
7.2.6.8. Rest Of Europe
7.2.6.8.1. Rest Of Europe Bone Graft And Substitute Market Size & Opportunities
7.3. Asia-pacific
7.3.1. Market Size & Estimates
7.3.2. Asia-pacific Bone Graft And Substitute Market Drivers
7.3.3. Asia-pacific Bone Graft And Substitute Market Challenges
7.3.4. Asia-pacific Bone Graft And Substitute Market Regulatory Framework
7.3.5. Key Players In Asia-pacific Bone Graft And Substitute Market
7.3.6. Country Analysis
7.3.6.1. China
7.3.6.1.1. China Bone Graft And Substitute Market Size & Opportunities
7.3.6.2. Japan
7.3.6.2.1. Japan Bone Graft And Substitute Market Size & Opportunities
7.3.6.3. India
7.3.6.3.1. India Bone Graft And Substitute Market Size & Opportunities
7.3.6.4. South Korea
7.3.6.4.1. South Korea Bone Graft And Substitute Market Size & Opportunities
7.3.6.5. Singapore
7.3.6.5.1. Singapore Bone Graft And Substitute Market Size & Opportunities
7.3.6.6. Australia & New Zealand
7.3.6.6.1. Australia & New Zealand Bone Graft And Substitute Market Size & Opportunities
7.3.6.7. Rest Of Asia-pacific
7.3.6.7.1. Rest Of Asia-pacific Bone Graft And Substitute Market Size & Opportunities
7.4. Rest Of World
7.4.1. Market Size & Estimates
7.4.2. Rest Of World Bone Graft And Substitute Market Drivers
7.4.3. Rest Of World Bone Graft And Substitute Market Challenges
7.4.4. Rest Of World Bone Graft And Substitute Market Regulatory Framework
7.4.5. Key Players In Rest Of World Bone Graft And Substitute Market
7.4.6. Regional Analysis
7.4.6.1. Latin America
7.4.6.1.1. Latin America Bone Graft And Substitute Market Size & Opportunities
7.4.6.2. Middle East & Africa
7.4.6.2.1. Middle East & Africa Bone Graft And Substitute Market Size & Opportunities
8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships & Agreements
8.1.4. Business Expansions & Divestitures
8.2. Company Profiles
8.2.1. Allosource Inc Plc
8.2.1.1. Company Overview
8.2.1.2. Product List
8.2.2. Arthrex
8.2.2.1. Company Overview
8.2.2.2. Product List
8.2.2.3. Strengths & Challenges
8.2.3. Baxter International Inc
8.2.3.1. Company Overview
8.2.3.2. Product List
8.2.3.3. Strengths & Challenges
8.2.4. Bioventus Llc
8.2.4.1. Company Overview
8.2.4.2. Product List
8.2.4.3. Strengths & Challenges
8.2.5. Depuy Synthes Companies
8.2.5.1. Company Overview
8.2.5.2. Product List
8.2.5.3. Strengths & Challenges
8.2.6. Integra Lifesciences
8.2.6.1. Company Overview
8.2.6.2. Product List
8.2.6.3. Strengths & Challenges
8.2.7. Mathys Ag
8.2.7.1. Company Overview
8.2.7.2. Product List
8.2.7.3. Strengths & Challenges
8.2.8. Medtronic Inc
8.2.8.1. Company Overview
8.2.8.2. Product List
8.2.8.3. Strengths & Challenges
8.2.9. Nuvasive Inc
8.2.9.1. Company Overview
8.2.9.2. Product List
8.2.9.3. Strengths & Challenges
8.2.10. Orthofix Holdings Inc
8.2.10.1. Company Overview
8.2.10.2. Product List
8.2.10.3. Strengths & Challenges
8.2.11. Sigmagraft
8.2.11.1. Company Overview
8.2.11.2. Product List
8.2.12. Smith & Nephew Plc
8.2.12.1. Company Overview
8.2.12.2. Product List
8.2.12.3. Strengths & Challenges
8.2.13. Stryker Corporation
8.2.13.1. Company Overview
8.2.13.2. Product List
8.2.13.3. Strengths & Challenges
8.2.14. Zimmer Biomet Holdings Inc
8.2.14.1. Company Overview
8.2.14.2. Product List
8.2.14.3. Strengths & Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings